Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B can increase body weight—Authors' reply

Eiichi Ogawa

doi:10.1111/apt.17910

Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B can increase body weight—Authors' reply

Internal Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	909-910
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	59
Issue number	7
DOIs	https://doi.org/10.1111/apt.17910
Publication status	Published - Apr 2024

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/apt.17910

Cite this

@article{3578dcaf5bfe41bd86ae3181f94faf8e,

title = "Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B can increase body weight—Authors' reply",

author = "Eiichi Ogawa",

year = "2024",

month = apr,

doi = "10.1111/apt.17910",

language = "English",

volume = "59",

pages = "909--910",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Letter

T2 - Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B can increase body weight—Authors' reply

AU - Ogawa, Eiichi

PY - 2024/4

Y1 - 2024/4

UR - http://www.scopus.com/inward/record.url?scp=85187171079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85187171079&partnerID=8YFLogxK

U2 - 10.1111/apt.17910

DO - 10.1111/apt.17910

M3 - Letter

C2 - 38462688

AN - SCOPUS:85187171079

SN - 0269-2813

VL - 59

SP - 909

EP - 910

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 7

ER -

Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B can increase body weight—Authors' reply

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this